Correction to “The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes”

IF 5.4 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes, Obesity & Metabolism Pub Date : 2025-03-13 DOI:10.1111/dom.16323

{"title":"Correction to “The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes”","authors":"","doi":"10.1111/dom.16323","DOIUrl":null,"url":null,"abstract":"Wang X, Pei J, Zheng K, Liu M, Hu X. The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes. Diabetes Obes Metab. 2025;27(3):1208-1216. doi:10.1111/dom.16112\n We failed to include the following important affiliation for the first author ‘Xiaopu Wang’:1. Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan, China.The author affiliations should read as:Xiaopu Wang MD1,2 | Junyu Pei MD1 | Keyang Zheng MD3 | Maojun Liu MD1 | Xinqun Hu MD11. Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan, China2. Libin Cardiovascular Institute of Alberta, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada3. Department of Cardiovascular Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaWe apologize for this error.","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":"27 5","pages":"2906"},"PeriodicalIF":5.4000,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dom.16323","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/dom.16323","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Wang X, Pei J, Zheng K, Liu M, Hu X. The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes. Diabetes Obes Metab. 2025;27(3):1208-1216. doi:10.1111/dom.16112

We failed to include the following important affiliation for the first author ‘Xiaopu Wang’:

1. Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

The author affiliations should read as:

Xiaopu Wang MD^1,2 | Junyu Pei MD¹ | Keyang Zheng MD³ | Maojun Liu MD¹ | Xinqun Hu MD¹

1. Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan, China

2. Libin Cardiovascular Institute of Alberta, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada

3. Department of Cardiovascular Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

We apologize for this error.

查看原文本刊更多论文

修正“HbA1c变异性对2型糖尿病患者强化血压控制效果的影响”。

王欣，裴杰，郑凯，刘敏，胡霞。HbA1c变异性对2型糖尿病患者强化血压控制效果的影响。中国糖尿病杂志，2015;27(3):1208-1216。doi: 10.1111 / dom.16112我们没有包括第一作者王晓普的以下重要从属关系：1。中南大学湘雅二医院心血管内科，湖南长沙。作者身份如下：王晓普MD1,2 b|裴俊宇MD1 |郑克阳MD3 |刘茂军MD1 |胡新群MD11。1 .中南大学湘雅第二医院心血管内科，湖南长沙；加拿大阿尔伯塔省卡尔加里大学利宾心血管研究所，健康科学中心，卡尔加里首都医科大学附属北京安贞医院心血管内科对此错误深表歉意。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes, Obesity & Metabolism 医学-内分泌学与代谢

CiteScore

10.90

自引率

6.90%

发文量

319

审稿时长

3-8 weeks

期刊介绍： Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.